Supplementary Table 2 from Phase II Study of Eribulin plus Pembrolizumab in Metastatic Soft-tissue Sarcomas: Clinical Outcomes and Biological Correlates

Candace L. Haddox, Michael J. Nathenson,Emanuele Mazzola,Jia-Ren Lin, Joanna Baginska, Allison Nau,Jason L. Weirather,Edwin Choy,Adrian Marino-Enriquez, Jeffrey A. Morgan, Gregory M. Cote,Priscilla Merriam,Andrew J. Wagner,Peter K. Sorger,Sandro Santagata,Suzanne George

crossref（2024）

引用 0|浏览2

暂无评分

摘要

Supplementary Table 2. Antibodies and dilutions used in Cyclic Immunofluorescence (CyCIF) with vendor, catalogue number, and dilution used for each marker.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要